Ra Capital Management, L.P. Adagio Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.81 - $10.77 $19 Million - $53.8 Million	-4,995,807 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.35 - $47.04 $2.19 Million - $16.2 Million	-344,323 Reduced 6.45%	4,995,807 $36.3 Million
Q3 2021 Nov 15, 2021	BUY	$20.88 - $56.08 $112 Million - $299 Million	5,340,130 New	5,340,130 $226 Million

64M

828K

23.4K

Ticker ADGI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 108,831,000
Market Cap $505M
Description
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.